Clinical trials
Active, not recruiting Carcinoma, Transitional Cell trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| BeiGene | 1 |
| Chang Gung Memorial Hospital | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Genentech, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 8 |
| Urinary Bladder Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Melanoma | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Stomach Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.